marketcaparena

KPTI

Karyopharm Therapeutics Inc.

Company overview

Market capitalization
$36.74M
Employees
228
Latest publication
2026-09-29
About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead compounds include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma; in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It also develops Selinexor for treating hematological and solid tumor malignancies, including multiple myeloma, endometrial cancer, myelofibrosis, and DLBCL; and ELTANEXOR for treating other myeloproliferative neoplasms and TP53 wild-type solid tumors. In addition, the company has license agreement with Menarini Group to develop and commercialize selinexor for human oncology indications; license agreement with Antengene Therapeutics Limited to develop and commercialize selinexor, eltanexor, and KPT-9274 for the treatment and/or prevention of human oncology indications, as well as verdinexor for the diagnosis, treatment, and/or prevention of human non-oncology indications; and distribution agreement for the commercialization of XPOVIO with FORUS Therapeutics Inc. Further, the company has a collaboration with Bristol Myers Squibb company to evaluate novel cereblon E3 ligase modulator agent mezigdomide in combination with Selinexor in patients with relapsed or refractory multiple myeloma. Karyopharm Therapeutics Inc. was incorporated in 2008 and is headquartered in Newton, Massachusetts.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Revenue33,432,000USD35,066,000USD34,079,000USD44,044,000USD37,929,000USD30,015,000USD30,542,000USD38,783,000USD
Research Development28,957,000USD33,785,000USD27,667,000USD30,544,000USD32,788,000USD34,618,000USD33,302,000USD36,134,000USD
Selling General Administrative25,916,000USD26,684,000USD22,772,000USD26,607,000USD28,477,000USD27,352,000USD27,190,000USD27,632,000USD
Total Operating Expenses55,958,000USD60,469,000USD50,439,000USD57,151,000USD61,265,000USD61,970,000USD60,492,000USD63,766,000USD
Operating Income-22,526,000USD-26,760,000USD-17,844,000USD-15,220,000USD-24,387,000USD-33,256,000USD-31,281,000USD-26,283,000USD
Total Other Income Expense Net-44,497,000USD4,369,000USD-84,421,000USD-17,873,000USD-12,825,000USD9,830,000USD392,000USD-5,761,000USD
Interest Income722,000USD511,000USD607,000USD553,000USD613,000USD1,000,000USD1,482,000USD1,832,000USD
Interest Expense13,144,000USD12,553,000USD12,619,000USD11,008,000USD11,228,000USD10,994,000USD11,204,000USD11,385,000USD
Income Before Tax-67,023,000USD-22,391,000USD-102,265,000USD-33,093,000USD-37,212,000USD-23,426,000USD-30,889,000USD-32,044,000USD
Income Tax Expense0USD1,000USD-67,000USD34,000USD40,000USD36,000USD-109,000USD28,000USD
Net Income-67,023,000USD-22,392,000USD-102,198,000USD-33,127,000USD-37,252,000USD-23,462,000USD-30,780,000USD-32,072,000USD
Cost Of Revenue—1,357,000USD1,484,000USD2,113,000USD1,051,000USD1,301,000USD1,331,000USD1,300,000USD
Gross Profit—33,709,000USD32,595,000USD41,931,000USD36,878,000USD28,714,000USD29,211,000USD37,483,000USD
Net Interest Income—-12,042,000USD-12,012,000USD-10,455,000USD-10,615,000USD-9,994,000USD-9,722,000USD-9,553,000USD
Tax Provision—1,000USD-67,000USD34,000USD40,000USD36,000USD-109,000USD28,000USD
Net Income From Continuing Ops—-22,392,000USD-102,198,000USD-33,127,000USD-37,252,000USD-23,462,000USD-30,780,000USD-32,072,000USD
Ebit—-26,760,000USD-89,646,000USD-22,638,000USD-25,984,000USD-12,432,000USD-19,685,000USD-20,659,000USD
Ebitda—-26,748,000USD-89,627,000USD-22,560,000USD-25,906,000USD-12,354,000USD-19,604,000USD-20,576,000USD
Depreciation And Amortization—12,000USD19,000USD78,000USD78,000USD78,000USD81,000USD83,000USD
Reconciled Depreciation—12,000USD19,000USD121,000USD78,000USD78,000USD81,000USD83,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue146,067,000USD145,237,000USD146,033,000USD157,074,000USD209,819,000USD108,085,000USD40,893,000USD30,336,000USD
Cost Of Revenue5,949,000USD6,007,000USD4,942,000USD5,213,000USD3,402,000USD2,705,000USD2,407,000USD161,372,000USD
Gross Profit140,118,000USD139,230,000USD141,091,000USD151,861,000USD206,417,000USD105,380,000USD38,486,000USD-131,036,000USD
Research Development125,617,000USD143,232,000USD138,750,000USD148,662,000USD160,842,000USD150,813,000USD122,340,000USD161,372,000USD
Selling General Administrative105,208,000USD115,441,000USD131,881,000USD145,401,000USD143,846,000USD126,417,000USD105,421,000USD48,847,000USD
Total Operating Expenses230,825,000USD258,673,000USD270,631,000USD294,063,000USD304,688,000USD277,230,000USD227,761,000USD210,219,000USD
Operating Income-90,707,000USD-119,443,000USD-129,540,000USD-142,202,000USD-98,271,000USD-171,850,000USD-189,275,000USD-179,883,000USD
Interest Income2,773,000USD7,400,000USD9,757,000USD2,359,000USD582,000USD2,820,000USD5,422,000USD4,028,000USD
Interest Expense45,849,000USD37,422,000USD23,823,000USD24,996,000USD26,046,000USD27,140,000USD15,647,000USD2,493,000USD
Net Interest Income-43,076,000USD-30,022,000USD-13,743,000USD-22,637,000USD-25,464,000USD-24,320,000USD-10,225,000USD1,535,000USD
Income Before Tax-195,996,000USD-76,365,000USD-142,776,000USD-164,922,000USD-123,820,000USD-195,964,000USD-199,550,000USD-178,381,000USD
Income Tax Expense43,000USD57,000USD323,000USD369,000USD268,000USD309,000USD40,000USD26,000USD
Tax Provision43,000USD57,000USD266,000USD369,000USD268,000USD309,000USD40,000USD26,000USD
Net Income-196,039,000USD-76,422,000USD-143,099,000USD-165,291,000USD-124,088,000USD-196,273,000USD-199,590,000USD-178,407,000USD
Net Income From Continuing Ops-196,039,000USD-76,422,000USD-139,768,000USD-165,291,000USD-124,088,000USD-196,273,000USD-199,590,000USD-178,407,000USD
Ebit-150,147,000USD-38,943,000USD-118,953,000USD-139,926,000USD-97,774,000USD-168,824,000USD-183,903,000USD-175,888,000USD
Ebitda-149,851,000USD-38,603,000USD-118,423,000USD-139,305,000USD-96,985,000USD-167,852,000USD-182,929,000USD-175,153,000USD
Depreciation And Amortization296,000USD340,000USD530,000USD621,000USD789,000USD972,000USD974,000USD735,000USD
Reconciled Depreciation296,000USD340,000USD566,000USD621,000USD789,000USD972,000USD974,000USD735,000USD
Total Other Income Expense Net-105,289,000USD43,078,000USD-13,236,000USD-22,720,000USD-25,549,000USD-24,114,000USD-10,275,000USD1,502,000USD
Non Operating Income Net Other———2,276,000USD497,000USD3,026,000USD5,372,000USD3,995,000USD
Net Income Applicable To Common Shares———-165,291,000USD-124,088,000USD-196,273,000USD-199,590,000USD-178,407,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets111,317,000USD131,417,000USD108,416,000USD96,232,000USD104,879,000USD127,711,000USD164,418,000USD189,476,000USD
Cash And Equivalents54,980,000USD———————
Total Current Assets106,378,000USD126,333,000USD103,146,000USD89,746,000USD97,870,000USD120,238,000USD156,492,000USD184,755,000USD
Other Current Assets7,408,000USD8,527,000USD9,186,000USD8,026,000USD8,249,000USD10,285,000USD12,275,000USD14,779,000USD
Total Liabilities441,485,000USD———————
Total Current Liabilities134,233,000USD117,302,000USD92,060,000USD87,157,000USD99,216,000USD90,370,000USD92,264,000USD61,493,000USD
Other Current Liabilities6,394,000USD———————
Other Non Current Liabilities336,000USD———————
Total Stockholder Equity-330,168,000USD-265,646,000USD-292,926,000USD-269,258,000USD-238,926,000USD-205,884,000USD-186,017,000USD-159,647,000USD
Total Equity Including Noncontrolling Interest-330,168,000USD———————
Inventory3,994,000USD3,599,000USD4,038,000USD3,966,000USD4,992,000USD4,769,000USD4,739,000USD4,672,000USD
Property Plant Equipment Net4,354,000USD4,500,000USD4,652,000USD4,802,000USD5,325,000USD5,799,000USD6,284,000USD3,081,000USD
Accounts Payable7,660,000USD4,279,000USD4,003,000USD5,392,000USD2,597,000USD5,872,000USD5,107,000USD5,783,000USD
Short Term Debt1,068,000USD33,250,000USD21,979,000USD14,594,000USD32,117,000USD25,386,000USD24,864,000USD3,668,000USD
Common Stock14,000USD14,000USD14,000USD13,000USD13,000USD13,000USD13,000USD13,000USD
Retained Earnings-1,848,914,000USD-1,781,891,000USD-1,759,499,000USD-1,657,301,000USD-1,624,174,000USD-1,586,922,000USD-1,563,460,000USD-1,532,680,000USD
Accumulated Other Comprehensive Income41,000USD43,000USD70,999USD-259,000USD-251,000USD-321,000USD-356,000USD-222,000USD
Total Liab—397,063,000USD401,342,000USD365,490,000USD343,805,000USD333,595,000USD350,435,000USD349,123,000USD
Other Current Liab—79,773,000USD66,078,000USD67,171,000USD64,502,000USD59,112,000USD62,293,000USD52,042,000USD
Capital Stock—14,000USD14,000USD13,000USD13,000USD13,000USD13,000USD13,000USD
Cash—90,850,000USD60,540,000USD37,672,000USD38,725,000USD38,783,000USD62,476,000USD72,828,000USD
Cash And Short Term Investments—90,850,000USD63,744,000USD45,877,000USD51,697,000USD69,941,000USD108,712,000USD133,526,000USD
Net Debt—140,024,000USD173,067,000USD158,751,000USD151,893,000USD147,920,000USD132,048,000USD121,432,000USD
Short Long Term Debt—32,232,000USD21,010,000USD12,750,000USD30,734,000USD24,459,000USD24,426,000USD—
Short Long Term Debt Total—230,874,000USD233,607,000USD196,423,000USD190,618,000USD186,703,000USD194,524,000USD194,260,000USD
Long Term Debt—192,156,000USD205,885,000USD176,743,000USD152,250,000USD154,832,000USD162,948,000USD190,592,000USD
Short Term Investments—0USD3,204,000USD8,205,000USD12,972,000USD31,158,000USD46,236,000USD60,698,000USD
Net Receivables—23,357,000USD26,178,000USD31,877,000USD32,932,000USD35,243,000USD30,766,000USD31,778,000USD
Property Plant Equipment Gross—4,500,000USD10,162,000USD4,802,000USD5,325,000USD5,799,000USD12,975,000USD3,081,000USD
Common Stock Shares Outstanding—24,715,000shares17,979,000shares8,669,000shares8,620,000shares8,470,000shares8,392,066shares8,333,999shares
Non Current Assets Total—5,084,000USD5,270,000USD6,486,000USD7,009,000USD7,473,000USD7,926,000USD4,721,000USD
Non Current Liabilities Total—279,760,999USD309,282,000USD278,333,000USD244,589,000USD243,225,000USD258,171,000USD287,630,000USD
Non Current Liabilities Other—278,000USD11,095,000USD14,118,000USD8,256,000USD5,146,000USD2,430,000USD6,184,000USD
Non Currrent Assets Other—267,000USD267,000USD1,334,000USD1,684,000USD1,674,000USD1,642,000USD1,640,000USD
Net Working Capital—9,031,000USD11,086,000USD2,589,000USD-1,346,000USD29,868,000USD64,228,000USD123,262,000USD
Unclassified Current Liabilities—-32,232,000USD-21,010,000USD-12,750,000USD-30,734,000USD-24,459,000USD-24,426,000USD—
Unclassified Non Current Liabilities—87,326,999USD92,302,000USD87,472,000USD84,083,000USD83,247,000USD92,793,000USD90,854,000USD
Unclassified Equity—1,516,174,000USD1,466,474,001USD1,388,276,000USD1,385,473,000USD1,381,333,000USD1,377,773,000USD1,373,229,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets108,416,000USD164,418,000USD240,438,000USD358,172,000USD305,305,000USD313,050,000USD294,963,000USD341,192,000USD
Other Current Assets9,186,000USD12,275,000USD12,473,000USD20,885,000USD20,388,000USD559,000USD1,485,000USD6,413,000USD
Total Liab401,342,000USD350,435,000USD376,644,000USD374,828,000USD384,978,000USD262,504,000USD245,189,000USD158,022,000USD
Total Stockholder Equity-292,926,000USD-186,017,000USD-136,206,000USD-16,656,000USD-79,673,000USD50,546,000USD49,774,000USD183,170,000USD
Other Current Liab66,078,000USD62,293,000USD63,048,000USD60,263,000USD69,799,000USD-6,367,000USD41,378,000USD327,000USD
Common Stock14,000USD13,000USD12,000USD12,000USD8,000USD7,000USD7,000USD6,000USD
Capital Stock14,000USD13,000USD12,000USD12,000USD8,000USD7,000USD7,000USD6,000USD
Retained Earnings-1,759,499,000USD-1,563,460,000USD-1,487,038,000USD-1,343,939,000USD-1,178,648,000USD-1,069,611,000USD-873,338,000USD-673,748,000USD
Cash60,540,000USD62,476,000USD52,231,000USD135,188,000USD190,459,000USD85,918,000USD128,858,000USD118,021,000USD
Cash And Short Term Investments63,744,000USD108,712,000USD191,443,000USD277,967,000USD228,615,000USD273,455,000USD263,972,000USD328,199,000USD
Total Current Assets103,146,000USD156,492,000USD233,921,000USD350,162,000USD275,606,000USD289,539,000USD273,665,000USD334,612,000USD
Total Current Liabilities92,060,000USD92,264,000USD69,479,000USD65,908,000USD73,718,000USD297,000USD46,350,000USD46,904,000USD
Net Debt173,067,000USD132,048,000USD124,785,000USD43,886,000USD-9,881,000USD32,010,000USD-19,001,000USD-15,357,000USD
Short Term Debt21,979,000USD24,864,000USD3,308,000USD2,872,000USD2,316,000USD1,917,000USD1,646,000USD32,883,000USD
Short Long Term Debt21,010,000USD24,426,000USD——————
Short Long Term Debt Total233,607,000USD194,524,000USD177,016,000USD179,074,000USD180,578,000USD119,845,000USD111,503,000USD135,547,000USD
Long Term Debt205,885,000USD162,948,000USD170,919,000USD170,105,000USD169,293,000USD117,928,000USD109,857,000USD102,664,000USD
Short Term Investments3,204,000USD46,236,000USD139,212,000USD142,779,000USD38,156,000USD163,322,000USD133,098,000USD210,178,000USD
Net Receivables26,178,000USD30,766,000USD26,962,000USD47,086,000USD22,497,000USD12,881,000USD7,862,000USD—
Inventory4,038,000USD4,739,000USD3,043,000USD4,224,000USD4,106,000USD2,644,000USD346,000USD—
Accounts Payable4,003,000USD5,107,000USD3,123,000USD2,773,000USD1,603,000USD4,450,000USD985,000USD4,332,000USD
Property Plant Equipment Net4,652,000USD6,284,000USD4,882,000USD7,377,000USD9,557,000USD2,219,000USD3,046,000USD3,863,000USD
Property Plant Equipment Gross10,162,000USD12,975,000USD11,447,000USD1,139,000USD1,642,000USD11,582,000USD13,663,000USD3,863,000USD
Accumulated Other Comprehensive Income71,000USD-356,000USD-161,000USD-638,000USD191,000USD518,000USD-37,000USD-244,000USD
Common Stock Shares Outstanding10,935,000shares8,124,199shares7,614,733shares5,458,066shares5,014,533shares72,044,000shares61,955,420shares56,780,000shares
Non Current Assets Total5,270,000USD7,926,000USD6,517,000USD8,010,000USD29,699,000USD23,511,000USD21,298,000USD6,580,000USD
Non Current Liabilities Total309,282,000USD258,171,000USD307,165,000USD308,920,000USD311,260,000USD262,207,000USD245,189,000USD111,118,000USD
Non Current Liabilities Other11,095,000USD2,430,000USD978,000USD72,005,000USD82,687,000USD84,373,000USD86,790,000USD—
Non Currrent Assets Other267,000USD1,642,000USD1,635,000USD633,000USD20,142,000USD-2,923,000USD16,236,000USD716,000USD
Net Working Capital11,086,000USD64,228,000USD164,442,000USD284,254,000USD201,888,000USD216,328,000USD232,220,000USD287,708,000USD
Unclassified Current Liabilities-21,010,000USD-24,426,000USD-25,066,000USD—-69,121,000USD-6,367,000USD——
Unclassified Non Current Liabilities92,302,000USD92,793,000USD135,268,000USD66,810,000USD-156,405,000USD-84,670,000USD-29,430,000USD-8,454,000USD
Unclassified Equity1,466,474,000USD1,377,773,000USD1,350,969,000USD1,327,897,000USD1,098,768,000USD1,119,625,000USD923,135,000USD857,150,000USD
Other Assets——1USD633,000USD45,565,000USD34,300,000USD714,000USD716,000USD
Current Deferred Revenue——25,066,000USD—69,121,000USD297,000USD2,341,000USD9,362,000USD
Net Tangible Assets———-16,656,000USD-79,673,000USD50,546,000USD49,774,000USD183,170,000USD
Other Liab————215,685,000USD144,576,000USD75,780,000USD8,454,000USD
Long Term Investments————0USD24,215,000USD2,016,000USD2,001,000USD
Unclassified Non Current Assets————-45,565,000USD-37,223,000USD——
Unclassified Current Assets—————24,215,000USD——
Deferred Long Term Liab——————2,192,000USD8,454,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Depreciation9,000USD
Stock Based Compensation4,936,000USD
Change To Account Receivables-3,693,000USD
Change To Inventory44,000USD
Change To Liabilities7,167,000USD
Change In Working Capital1,786,000USD
Operating Cash Flow-47,659,000USD
Net Investments-6,836,000USD
Investing Cash Flow-6,836,000USD
Common Stock Issuance574,000USD
Unclassified Financing Cash Flow48,330,000USD
Financing Cash Flow48,904,000USD
Effect Of Forex Changes On Cash-2,000USD
Change In Cash-5,593,000USD
End Cash Flow55,298,000USD
SourceDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-22,392,000USD-102,198,000USD-33,127,000USD-37,252,000USD-23,462,000USD-30,780,000USD-32,072,000USD23,792,000USD
Depreciation12,000USD2,464,000USD121,000USD-42,000USD78,000USD2,438,000USD2,490,000USD91,000USD
Stock Based Compensation3,007,000USD3,903,000USD2,803,000USD3,784,000USD3,560,000USD3,864,000USD4,182,000USD5,410,000USD
Other Non Cash Items-4,199,000USD78,503,000USD10,096,000USD4,763,000USD-17,635,000USD-11,416,000USD-1,546,000USD-58,317,000USD
Change To Account Receivables2,821,000USD5,699,000USD1,055,000USD2,311,000USD-4,477,000USD1,012,000USD6,217,000USD-6,913,000USD
Change To Inventory439,000USD-72,000USD1,026,000USD-223,000USD-30,000USD-67,000USD-1,196,000USD-707,000USD
Change In Working Capital3,851,000USD5,500,000USD14,247,000USD10,050,000USD-1,525,000USD10,084,000USD7,493,000USD-9,474,000USD
Total Cash From Operating Activities-22,728,000USD-11,828,000USD-5,860,000USD-18,697,000USD-38,984,000USD-25,810,000USD-19,453,000USD-38,498,000USD
Capital Expenditures0USD0USD0USD0USD0USD-53,000USD0USD0USD
Free Cash Flow-22,728,000USD-11,828,000USD-5,860,000USD-18,697,000USD-38,984,000USD-25,756,999USD-19,453,000USD-38,498,000USD
Investments3,200,000USD5,000,000USD4,805,000USD18,285,000USD15,288,000USD14,797,000USD7,474,000USD51,262,000USD
Total Cashflows From Investing Activities3,200,000USD5,000,000USD4,805,000USD18,285,000USD15,288,000USD14,797,000USD7,474,000USD51,262,000USD
Total Cash From Financing Activities49,802,000USD29,692,000USD0USD356,000USD0USD680,000USD0USD40,966,000USD
Issuance Of Capital Stock50,233,000USD———0USD———
Change In Cash30,310,000USD22,869,000USD-1,053,000USD-48,000USD-23,691,000USD-10,353,000USD-11,943,000USD53,719,000USD
Begin Period Cash Flow60,540,000USD38,022,000USD39,075,000USD39,123,000USD62,814,000USD73,167,000USD85,110,000USD31,087,000USD
End Period Cash Flow90,850,000USD60,891,000USD38,022,000USD39,075,000USD39,123,000USD62,814,000USD73,167,000USD84,806,000USD
Other Cashflows From Financing Activities-431,000USD——356,000USD—680,000USD-118,697,000USD40,966,000USD
Unclassified Operating Cash Flow-3,007,000USD———————
Net Borrowings—27,000,000USD0USD——40,518,000USD0USD—
Unclassified Financing Cash Flow—2,692,000USD———-40,518,000USD7,697,000USD—
Other Cashflows From Investing Activities—————14,744,000USD7,474,000USD51,262,000USD
Unclassified Investing Cash Flow—————-14,691,000USD-7,474,000USD-51,262,000USD
Sale Purchase Of Stock——————111,000,000USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-196,039,000USD-76,422,000USD-143,099,000USD-165,291,000USD-124,088,000USD-196,273,000USD-199,590,000USD-178,407,000USD
Depreciation-114,000USD340,000USD530,000USD621,000USD789,000USD972,000USD974,000USD735,000USD
Stock Based Compensation14,050,000USD18,426,000USD21,709,000USD35,399,000USD29,783,000USD24,407,000USD15,291,000USD17,275,000USD
Other Non Cash Items78,462,000USD-69,528,000USD-3,278,000USD-294,000USD8,135,000USD8,400,000USD7,193,000USD1,420,000USD
Change To Account Receivables4,588,000USD-3,804,000USD20,124,000USD-5,084,000USD-9,616,000USD-5,019,000USD-7,862,000USD-7,862,000USD
Change To Inventory701,000USD-1,696,000USD1,181,000USD-118,000USD-1,462,000USD-2,627,000USD-346,000USD-346,000USD
Change In Working Capital28,272,000USD-302,000USD31,415,000USD-19,989,000USD-23,189,000USD1,356,000USD-13,308,000USD-169,000USD
Total Cash From Operating Activities-75,369,000USD-127,486,000USD-92,723,000USD-149,554,000USD-107,116,000USD-160,234,000USD-190,822,000USD-159,117,000USD
Capital Expenditures0USD-142,000USD0USD-118,000USD-5,712,000USD-145,000USD-206,000USD-2,363,000USD
Free Cash Flow-75,369,000USD-127,628,000USD-92,723,000USD-149,672,000USD-112,828,000USD-160,379,000USD-191,028,000USD-161,480,000USD
Investments43,378,000USD95,473,000USD-84,201,000USD-104,138,000USD147,552,000USD-53,540,000USD78,656,000USD-105,301,000USD
Total Cashflows From Investing Activities43,378,000USD95,473,000USD7,940,000USD-104,256,000USD141,840,000USD-53,685,000USD78,450,000USD-107,664,000USD
Net Borrowings27,000,000USD83,300,000USD0USD0USD———166,885,000USD
Total Cash From Financing Activities30,048,000USD41,646,000USD1,124,000USD193,738,000USD73,648,000USD172,083,000USD124,305,000USD316,109,000USD
Issuance Of Capital Stock8,750,000USD0USD154,679,000USD189,761,000USD9,903,000USD161,776,000USD46,191,000USD145,705,000USD
Change In Cash-1,923,000USD9,622,000USD-83,693,000USD-60,560,000USD108,324,000USD-41,568,000USD11,952,000USD49,250,000USD
Begin Period Cash Flow62,814,000USD53,192,000USD136,885,000USD197,445,000USD89,121,000USD130,689,000USD118,737,000USD69,487,000USD
End Period Cash Flow60,891,000USD62,814,000USD53,192,000USD136,885,000USD197,445,000USD89,121,000USD130,689,000USD118,737,000USD
Other Cashflows From Financing Activities30,048,000USD-43,106,000USD1,124,000USD3,977,000USD3,745,000USD10,307,000USD78,114,000USD3,519,000USD
Unclassified Financing Cash Flow-35,750,000USD-109,548,000USD-154,679,000USD185,784,000USD66,158,000USD151,469,000USD41,686,000USD142,186,000USD
Sale Purchase Of Stock—111,000,000USD—3,977,000USD3,745,000USD10,307,000USD4,505,000USD3,519,000USD
Unclassified Investing Cash Flow——92,141,000USD104,256,000USD5,500,000USD53,540,000USD-78,656,000USD105,301,000USD
Change To Liabilities———-8,366,000USD13,413,000USD15,626,000USD5,211,000USD9,875,000USD
Cash And Cash Equivalents Changes———-60,072,000USD108,372,000USD-41,836,000USD11,933,000USD49,328,000USD
Other Cashflows From Investing Activities———-104,256,000USD-5,500,000USD-53,540,000USD78,656,000USD-105,301,000USD
Unclassified Operating Cash Flow————1,454,000USD———
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q3 2023Quarterly · 2023-09-30ProductLicense And Other5,802,000USD0000950170-24-121076
Q3 2023Quarterly · 2023-09-30ProductProduct30,207,000USD0000950170-24-121076
Q1 2022Quarterly · 2022-03-31ProductLicense And Other19,370,000USD0000950170-23-017483
Q1 2022Quarterly · 2022-03-31ProductProduct28,300,000USD0000950170-23-017483
Q1 2022Quarterly · 2022-03-31ProductRoyalty300,000USD0000950170-23-017483
Q4 2021Quarterly · 2021-12-31ProductLicense And Other96,466,000USDLegacy provider
Q4 2021Quarterly · 2021-12-31ProductProduct29,803,000USDLegacy provider
FY 2021Yearly · 2021-12-31ProductLicense And Other111,383,000USD0000950170-24-022650
FY 2021Yearly · 2021-12-31ProductProduct98,436,000USD0000950170-24-022650
FY 2021Yearly · 2021-12-31ProductRoyalty800,000USD0000950170-24-022650
Q3 2021Quarterly · 2021-09-30ProductLicense And Other10,966,000USD0000950170-22-021917
Q3 2021Quarterly · 2021-09-30ProductProduct26,723,000USD0000950170-22-021917
Q3 2021Quarterly · 2021-09-30ProductRoyalty200,000USD0000950170-22-021917
Q2 2021Quarterly · 2021-06-30ProductLicense And Other2,422,000USD0000950170-22-014788
Q2 2021Quarterly · 2021-06-30ProductProduct20,179,000USD0000950170-22-014788
Q2 2021Quarterly · 2021-06-30ProductRoyalty100,000USD0000950170-22-014788
Q1 2021Quarterly · 2021-03-31ProductLicense And Other1,529,000USD0000950170-22-007564
Q1 2021Quarterly · 2021-03-31ProductProduct21,731,000USD0000950170-22-007564
Q4 2020Quarterly · 2020-12-31ProductLicense And Other14,882,000USDLegacy provider
Q4 2020Quarterly · 2020-12-31ProductProduct20,218,000USDLegacy provider
FY 2020Yearly · 2020-12-31ProductLicense And Other31,875,000USD0000950170-23-003129
FY 2020Yearly · 2020-12-31ProductProduct76,210,000USD0000950170-23-003129
Q3 2020Quarterly · 2020-09-30ProductLicense And Other3,000USD0000950170-21-002729
Q3 2020Quarterly · 2020-09-30ProductProduct21,330,000USD0000950170-21-002729
FY 2019Yearly · 2019-12-31ProductLicense And Other10,353,000USD0000950170-22-002548
FY 2019Yearly · 2019-12-31ProductProduct30,540,000USD0000950170-22-002548
FY 2018Yearly · 2018-12-31ProductLicense And Other30,336,000USD0001193125-21-054811
FY 2018Yearly · 2018-12-31ProductProduct0USD0001193125-21-054811

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.